211
Participants
Start Date
April 30, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
January 31, 2012
AZD0530
oral once daily dose
Carboplatin
intravenous injection
Paclitaxel
intravenous infusion
Research Site, Pleven
Research Site, Plovdiv
Research Site, Sofia
Research Site, Varna
Research Site, Edmonton
Research Site, Vancouver
Research Site, St. John's
Research Site, Ottawa
Research Site, Toronto
Research Site, Montreal
Research Site, Québec
Research Site, Sherbrooke
Research Site, Aalborg
Research Site, Herning
Research Site, Næstved
Research Site, Paris
Research Site, Avignon
Research Site, Bordeaux
Research Site, Caen
Research Site, Lyon
Research Site, Montpellier
Research Site, Nantes
Research Site, Pierre-Bénite
Research Site, Reims
Research Site, Vandœuvre-lès-Nancy
Research Site, Amsterdam
Research Site, Leiden
Research Site, Nijmegen
Research Site, The Hague
Research Site, Bergen
Research Site, Oslo
Research Site, Lima
Research Site, Coimbra
Research Site, Funchal
Research Site, Lisbon
Research Site, Porto
Research Site, Baia Mare
Research Site, Alba Iulia
Research Site, Bucharest
Research Site, Cluj-Napoca
Research Site, Kazan'
Research Site, Moscow
Research Site, Nizhny Novgorod
Research Site, Saint Petersburg
Research Site, Córdoba
Research Site, Barcelona
Research Site, Hospitalet Dellobregat(barcelo
Research Site, Madrid
Research Site, Valencia
Research Site, Coventry
Lead Sponsor
AstraZeneca
INDUSTRY